3L3N | Hydrolase | date | Dec 17, 2009 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Testis Ace Co-Crystal Structure With Novel Inhibitor Lisw | ||||||||||||||
authors | J.M.Watermeyer, W.L.Kroger, H.G.O'Neil, B.T.Sewell, E.D.Sturrock | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Angiotensin-Converting Enzyme Chain: A Fragment: Peptidase M2 2, Residues 642-1232 Synonym: Ace, Dipeptidyl Carboxypeptidase I, Kininase II, Angiotensin-Converting Enzyme, Soluble Form; Ec: 3.4.15.1, 3.2.1.- Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Ace, Dcp, Dcp1 Expression_system: Cricetulus Griseus Expression_system_common: Chinese Hamster Expression_system_taxid: 10029 Expression_system_strain: Cho-K1 Expression_system_vector_type: Plasmid Expression_system_plasmid: Plen | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.30 Å | ||||||||||||
ligand | CL, FUC, LSW, NAG, ZN BindingDB | enzyme | Hydrolase E.C.3.4.15.1 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Characterisation of domain-selective inhibitor binding in angiotensin-converting enzyme using a novel derivative of lisinopril., Watermeyer JM, Kroger WL, O'Neill HG, Sewell BT, Sturrock ED, Biochem J. 2010 Mar 17. PMID:20233165 |
Data retrieval |
View 3L3N in 3D |
Visual 3D analysis of 3L3N |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3L3N |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |